Our previous studies, as well as studies from Ono’s group, have demonstrated that overexpression of CTMP can induce Akt phosphorylation, leading to increased Akt activity and facilitating apoptosis evasion, glucose metabolism, and breast cancer progression [16–18]. The gene discussed is AKT1; the disease is breast cancer.